Orchid Research Laboratories

Orchid Research Laboratories Limited (ORLL) is the drug discovery and development subsidiary of Orchid Pharma, an Indian pharmaceutical company. The company focuses on identifying and developing novel small molecule therapeutics across several therapeutic areas, including inflammation, metabolic diseases, and oncology. ORLL has historically utilized its expertise in medicinal chemistry to build a pipeline of candidates, some of which have reached clinical-stage testing. Following the corporate restructuring and acquisition of its parent company, Orchid Pharma, by Dhanuka Laboratories, the research arm continues to support the group's innovation efforts, particularly in the development of novel antibiotics and anti-infectives.